source
- Life insurers deem active-surveillance prostate cancer 'untreated' and deny term coverage, says patientHoward Wolinsky, a medical journalist, recounts that after his term life policy expired, eight insurers rejected his application because they considered his prostate cancer, managed by active surve…
- Epkinly shows 51% PFS boost in frontline DLBCL, may become new standard of careAbbVie and Genmab reported that their bispecific antibody Epkinly achieved a substantial gain in progression‑free survival when added to the standard R‑CHOP regimen in newly diagnosed diffuse large…